Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
17 (1y: -41%)
Market Cap 909.19 M P/E(ttm) 200.10
Enterprise Value 888.65 M P/B 2.20
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry		 vs
history
Cash to Debt 1.23
VOLC's Cash to Debt is ranked lower than
58% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3750.67 vs. VOLC: 1.23 )
VOLC' s 10-Year Cash to Debt Range
Min: 0.33   Max: No Debt
Current: 1.23
Equity to Asset 0.339
VOLC's Equity to Asset is ranked higher than
66% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 0.53 vs. VOLC: 0.339 )
VOLC' s 10-Year Equity to Asset Range
Min: -0.94   Max: 0.84
Current: 0.34
-0.94
0.84
Interest Coverage 2.8
VOLC's Interest Coverage is ranked lower than
67% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 420.30 vs. VOLC: 2.8 )
VOLC' s 10-Year Interest Coverage Range
Min: 3   Max: No Debt
Current: 2.8
F-Score: 5
Z-Score: 2.07
M-Score: -2.65
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry		 vs
history
Operating margin (%) 5.10
VOLC's Operating margin (%) is ranked higher than
58% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 5.80 vs. VOLC: 5.10 )
VOLC' s 10-Year Operating margin (%) Range
Min: -25.4   Max: 7.4
Current: 5.1
-25.4
7.4
Net-margin (%) 2.1
VOLC's Net-margin (%) is ranked higher than
50% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.25 vs. VOLC: 2.1 )
VOLC' s 10-Year Net-margin (%) Range
Min: -64.4   Max: 11.1
Current: 2.1
-64.4
11.1
ROE (%) 2
VOLC's ROE (%) is ranked lower than
53% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 4.80 vs. VOLC: 2 )
VOLC' s 10-Year ROE (%) Range
Min: -13.5   Max: 11.2
Current: 2
-13.5
11.2
ROA (%) 0.9
VOLC's ROA (%) is ranked lower than
53% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.40 vs. VOLC: 0.9 )
VOLC' s 10-Year ROA (%) Range
Min: -27.4   Max: 7.7
Current: 0.9
-27.4
7.7
ROC (Joel Greenblatt) (%) 10.90
VOLC's ROC (Joel Greenblatt) (%) is ranked higher than
58% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 14.00 vs. VOLC: 10.90 )
VOLC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -95.3   Max: 16.4
Current: 10.9
-95.3
16.4
Revenue Growth (%) 10.1
VOLC's Revenue Growth (%) is ranked higher than
96% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. VOLC: 10.1 )
VOLC' s 10-Year Revenue Growth (%) Range
Min: -28.3   Max: 14.8
Current: 10.1
-28.3
14.8
ยป VOLC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

VOLC Guru Trades in Q2 2012

Pioneer Investments 117,358 sh (New)
Jim Simons 154,100 sh (New)
RS Investment Management Sold Out
Manning & Napier Advisors, Inc 2,847,380 sh (-8.36%)
Steven Cohen 353,402 sh (-16.33%)
» More
Q3 2012

VOLC Guru Trades in Q3 2012

Paul Tudor Jones 10,100 sh (New)
Jim Simons Sold Out
Pioneer Investments Sold Out
Manning & Napier Advisors, Inc 2,738,500 sh (-3.82%)
Steven Cohen 2,102 sh (-99.41%)
» More
Q4 2012

VOLC Guru Trades in Q4 2012

Steven Cohen 135,196 sh (+6331.78%)
Paul Tudor Jones 16,600 sh (+64.36%)
Manning & Napier Advisors, Inc 4,185,305 sh (+52.83%)
» More
Q1 2013

VOLC Guru Trades in Q1 2013

Jim Simons 99,900 sh (New)
Steven Cohen 965,569 sh (+614.2%)
Manning & Napier Advisors, Inc 4,749,785 sh (+13.49%)
Paul Tudor Jones Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with VOLC

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
George Soros 2011-12-31 Sold Out 0.03%$21.76 - $30.57 $ 17-30%0
George Soros 2011-09-30 Reduce -35.69%0.02%$26.22 - $33.51 $ 17-44%67200
George Soros 2011-06-30 New Buy0.05%$24.51 - $31.81 $ 17-40%104500
Premium More recent guru trades are included for Premium Members only!!

Top Ranked Articles about Volcano Corporation

Weekly Guru Bargains Highlights: VOLC, SAPMY, BVN, NEM, TFM
May 13, 2013
According to GuruFocus updates, these stocks have declined the most since Gurus have bought. Read more...

Ratios

vs
industry		 vs
history
P/E(ttm) 200.10
VOLC's P/E(ttm) is ranked higher than
56% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 24.10 vs. VOLC: 200.10 )
VOLC' s 10-Year P/E(ttm) Range
Min: 31.53   Max: 332.21
Current: 200.1
31.53
332.21
P/B 2.20
VOLC's P/B is ranked lower than
70% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. VOLC: 2.20 )
VOLC' s 10-Year P/B Range
Min: 1.43   Max: 11.72
Current: 2.2
1.43
11.72
P/S 2.40
VOLC's P/S is ranked lower than
77% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. VOLC: 2.40 )
VOLC' s 10-Year P/S Range
Min: 0.68   Max: 6.89
Current: 2.4
0.68
6.89
EV-to-EBIT 55.6
VOLC's EV-to-EBIT is ranked lower than
55% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 16.25 vs. VOLC: 55.6 )
VOLC' s 10-Year EV-to-EBIT Range
Min: 42.5   Max: 142
Current: 55.6
42.5
142

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 11
VOLC's Price/Net Current Asset Value is ranked higher than
84% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 8.90 vs. VOLC: 11 )
VOLC' s 10-Year Price/Net Current Asset Value Range
Min: 13.2   Max: 22.2
Current: 11
13.2
22.2
Price/Tangible Book 3
VOLC's Price/Tangible Book is ranked higher than
75% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.80 vs. VOLC: 3 )
VOLC' s 10-Year Price/Tangible Book Range
Min: 2.2   Max: 5.7
Current: 3
2.2
5.7
Price/DCF (Projected) 4.2
VOLC's Price/DCF (Projected) is ranked higher than
98% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.25 vs. VOLC: 4.2 )
VOLC' s 10-Year Price/DCF (Projected) Range
Min: 5.1   Max: 10.7
Current: 4.2
5.1
10.7
Price/Median PS Value 0.6
VOLC's Price/Median PS Value is ranked higher than
81% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 0.80 vs. VOLC: 0.6 )
VOLC' s 10-Year Price/Median PS Value Range
Min: 0.6   Max: 1.2
Current: 0.6
0.6
1.2
Price/Graham Number 4
VOLC's Price/Graham Number is ranked higher than
96% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.80 vs. VOLC: 4 )
VOLC' s 10-Year Price/Graham Number Range
Min: 2.5   Max: 8.4
Current: 4
2.5
8.4
Earnings Yield (Greenblatt) 1.80
VOLC's Earnings Yield (Greenblatt) is ranked higher than
65% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 5.95 vs. VOLC: 1.80 )
VOLC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.7   Max: 2.4
Current: 1.8
0.7
2.4
Forward Rate of Return (Yacktman) -0.69
VOLC's Forward Rate of Return (Yacktman) is ranked lower than
606060% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.03 vs. VOLC: -0.69 )
VOLC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -2.2   Max: -0.4
Current: -0.69
-2.2
-0.4

Business Description

Volcano Corporation designs, develops, manufactures and commercializes a suite of intravascular ultrasound (IVUS) and functional measurement (FM) products that enhance the diagnosis and treatment of vascular and structural heart disease. The company is also developing ultra-high resolution Optical Coherence Tomography (OCT) systems and catheters, Forward-Looking IVUS or FLIVUS systems and catheters and image-guided therapy products. The company's FM offerings include consoles and single-use pressure and flow guide wires used to measure the pressure and flow characteristics of blood around plaque enabling physicians to gauge the plaque's physiological impact on blood flow and pressure. The company's FM products consist of pressure and flow consoles and single-procedure disposable pressure and flow guide wires. Volcano's FM products consist of pressure and flow consoles and single-procedure disposable pressure and flow guide wires. The company's consoles are mobile, proprietary and high speed electronic systems with different functionalities and sizes designed and manufactured to process the signals received from only its guide wires. Volcano's IVUS products consist of ultrasound consoles, single-procedure disposable phased array and rotational IVUS imaging catheters and additional functionality options such as virtual histology (VH), IVUS tissue characterization and ChromaFlo stent apposition analysis. The company's IVUS consoles are marketed as stand-alone units or customized units that could be integrated into a variety of hospital-based interventional surgical suites called catheterization laboratories. The company's IVUS consoles have been designed to serve as a multi-modality platform for its phased array and rotational IVUS catheters, fractional flow reserve, or FFR, pressure wires and Medtronic's Pioneer reentry device. The s5 family of consoles, which became Volcano's primary console following its full commercial launch in July 2006, is smaller, lighter and less expensive to manufacture, and has enhanced functionality. The company's IVUS products incorporate key features that add valuable clinical functionality addressing a number of the historical limitations of conventional IVUS and it intend to incorporate additional functionality in the future. Volcano's manufacturing facility is located in Rancho Cordova, California, where it produces IVUS consoles, FM consoles, IVUS catheters and FM guide wires. The company's console manufacturing strategy is to use third-party manufacturing partners to produce circuit boards and mechanical sub-assemblies.
Company Website
SEC Reports
Industry: Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ
Traded in other countries:VQY.Germany
ยป More Articles for VOLC

Headlines

Articles On GuruFocus.com
Weekly Guru Bargains Highlights: GOLD, GFI, SAPMY, APPL, VOLC May 20 2013 
Weekly Guru Bargains Highlights: VOLC, SAPMY, BVN, NEM, TFM May 13 2013 
Weekly Guru Bargains Highlights: GOLD, NEM, ABX, VOLC, GFI May 06 2013 
Weekly 3-Year Low Highlights: PACT, ATI, VLY, VOLC Apr 28 2013 
Weekly Guru Bargains Highlights: AAPL, AEM, VOLC, ABX, TFM Apr 28 2013 
Volcano Corp. (VOLC) President & CEO R Scott Huennekens sells 37,500 Shares Mar 08 2011 
Volcano Corp. (VOLC) CFO John T Dahldorf sells 1,724 Shares Mar 01 2011 
Volcano Corp. (VOLC) President & CEO R Scott Huennekens sells 5,851 Shares Mar 01 2011 
Volcano Corp. (VOLC) President & CEO R Scott Huennekens sells 43,315 Shares Feb 08 2011 
Volcano Corp. (VOLC) CFO John T Dahldorf sells 1,311 Shares Feb 08 2011 

More From Our Partners
Volcano Announces Preliminary Results from the ADVISE II Trial May 23 2013 - BENZINGA

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial